W3P-87302-25049 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-21
Dose 1 — Pfizer-BioNTech
2020-12-22
Registered in v-safe
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-28
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-04
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-11
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-13
Dose 2 — Pfizer-BioNTech
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-20
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-27
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-03
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-10
Survey response — day 28, dose 2
MedDRA: Heavy menstrual bleeding — Feeling: Good

Free text: Heavy menstrual periods x 2

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-17
Survey response — day 35, dose 2
MedDRA: Heavy menstrual bleeding — Feeling: Good

Free text: Heavier men trial cramps and increased bleeding than baseline

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-24
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-14
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-14
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-17
Dose 3 — Pfizer-BioNTech
2022-01-14
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-04-21
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-10-17
Survey response — 12 months, dose 3
MedDRA: Asthma, COVID-19, Pre-existing disease, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: COVID caused sinus infection and my first asthma flare in 5 years

MedDRA releases: 2024-11 · check-in free text available
2022-10-17
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-10-18
Call successful
Not applicable - Accidental Reporting

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-21	Pfizer-BioNTech
2	2021-01-13	Pfizer-BioNTech
3	2021-10-17	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-10-17	Successful 2022-10-18	Not applicable - Accidental Reporting

Free text

Release 4 — day 28, dose 2

2021-02-10

Symptoms: Heavy menstrual periods x 2

Release 4 — day 35, dose 2

2021-02-17

Symptoms: Heavier men trial cramps and increased bleeding than baseline

Release 12 — 12 months, dose 3

2022-10-17

Symptoms: COVID caused sinus infection and my first asthma flare in 5 years

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Asthma	·	·	✓
SD	COVID-19	·	·	✓
SD	Heavy menstrual bleeding	✓	✓	✓
SD	Pre-existing disease	·	·	✓
SD	Sinusitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release